Target intelligence / Profile preview

D-alanyl-D-alanine terminus of peptidoglycan

Molecular classification
Other
01

Overview

The **D-alanyl-D-alanine terminus of peptidoglycan** is a structural dipeptide motif found at the end of the pentapeptide side chains within the peptidoglycan of bacterial cell walls[1][4][6]. This terminal moiety is critical for the cross-linking of glycan chains during cell wall synthesis, a reaction catalyzed by transpeptidase enzymes[6]. The D-alanyl-D-alanine motif is specifically recognized and bound by several glycopeptide antibiotics, including vancomycin, which inhibits cell wall biosynthesis by blocking the action of transpeptidases, resulting in compromised cell wall integrity and eventual bacterial lysis[1]. Drugs targeting this terminus exploit its absence in human cells, providing selective antibacterial activity[1]. However, bacterial resistance can occur if the motif is replaced by D-alanyl-D-lactate, as seen in vancomycin-resistant enterococci[1]. This target is not a protein, transporter, or receptor but rather a specific structural motif essential for the viability of many bacteria.

Other names
D-Ala-D-Ala terminusD-alanyl-D-alanine dipeptide terminusD-alanyl-D-alanine motifD-alanyl-D-alanine end
02

Mechanism of action

Inhibition of transpeptidase-mediated cross-linking of peptidoglycan by drug binding to D-alanyl-D-alanine terminus Prevention of peptidoglycan polymerization, leading to cell wall weakening and bacterial lysis

03

Biological functions

Cell wall synthesisPeptidoglycan cross-linkingStructural integrity of bacterial cell wall
04

Disease associations

Infection
05

Safety considerations

Selectivity: This motif is absent in mammalian cells, providing high bacterial selectivity for inhibitors but potential for resistanceResistance: Bacteria may develop resistance by replacing the D-alanyl-D-alanine motif with D-alanyl-D-lactate (vancomycin resistance mechanism)
06

Interacting drugs

Vancomycin

4 more in the full profile.

Beyond the preview

Go deeper on D-alanyl-D-alanine terminus of peptidoglycan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-alanyl-D-alanine terminus of peptidoglycan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call